<p>Scenario A (blue curve) estimated survival based on registry data, which, although collected prospectively during clinical routine, were not up to date for every patient at the study end. Scenario B (red curve), however, estimated survival of the same study population based on a comprehensive survey performed at the study end. Completeness of follow-up differed significantly between scenarios as expressed as follow-up index (FUI, see text). Thereby, scenario A (FUI 0.57±0.35) underestimated effective mortality by almost 30% (scenario B; FUI 1.0±0).</p
National audienceMedian follow-up is often used to assess the quality of follow-up in longitudinal s...
<p>Average follow-up time: 4.8 years. Total follow-up time: 112,820 years. Log rank survival functio...
<p>(A) OS in the entire cohort (n = 104) at 2 years was 87.3% (95% CI, 80.5–94.1%) and 75.6% (95% CI...
BACKGROUND Current reporting guidelines do not call for standardised declaration of follow-up com...
<p>Patients were grouped into equally sized quartiles according to FUI (quartile 1 with highest FUIs...
<p>Kaplan-Meier survival curve for all study participants from randomization to end of extended foll...
(FUI) describes follow-up completeness at a given study end date as ratio between the investigated ...
<p>After disease onset, the 1-year survival rate was 93.2%, 3-year survival rate was 80.7% and 5-yea...
<p>Kaplan-Meier survival curve censoring deaths before day 90 of follow-up (end point of the RENAL S...
(a) Progression-free survival and (b) overall survival for patients with more than 70% reduction in ...
<p>The figure shows the comparison between the real survival curve provided by a breast cancer datas...
<p>Blue, low emphysema category; green, medium emphysema category; orange, high emphysema category. ...
<p>Survival curves out to 4.5 years of follow up shown above and Kaplan-Meier estimates of 12-month ...
<p>Kaplan Meier Curves displaying that the significant effect of appropriate shocks on survival in t...
Kaplan-Meier plot showing survival of participants during two years of follow up after completion of...
National audienceMedian follow-up is often used to assess the quality of follow-up in longitudinal s...
<p>Average follow-up time: 4.8 years. Total follow-up time: 112,820 years. Log rank survival functio...
<p>(A) OS in the entire cohort (n = 104) at 2 years was 87.3% (95% CI, 80.5–94.1%) and 75.6% (95% CI...
BACKGROUND Current reporting guidelines do not call for standardised declaration of follow-up com...
<p>Patients were grouped into equally sized quartiles according to FUI (quartile 1 with highest FUIs...
<p>Kaplan-Meier survival curve for all study participants from randomization to end of extended foll...
(FUI) describes follow-up completeness at a given study end date as ratio between the investigated ...
<p>After disease onset, the 1-year survival rate was 93.2%, 3-year survival rate was 80.7% and 5-yea...
<p>Kaplan-Meier survival curve censoring deaths before day 90 of follow-up (end point of the RENAL S...
(a) Progression-free survival and (b) overall survival for patients with more than 70% reduction in ...
<p>The figure shows the comparison between the real survival curve provided by a breast cancer datas...
<p>Blue, low emphysema category; green, medium emphysema category; orange, high emphysema category. ...
<p>Survival curves out to 4.5 years of follow up shown above and Kaplan-Meier estimates of 12-month ...
<p>Kaplan Meier Curves displaying that the significant effect of appropriate shocks on survival in t...
Kaplan-Meier plot showing survival of participants during two years of follow up after completion of...
National audienceMedian follow-up is often used to assess the quality of follow-up in longitudinal s...
<p>Average follow-up time: 4.8 years. Total follow-up time: 112,820 years. Log rank survival functio...
<p>(A) OS in the entire cohort (n = 104) at 2 years was 87.3% (95% CI, 80.5–94.1%) and 75.6% (95% CI...